Poincloux Renaud, Al Saati Talal, Maridonneau-Parini Isabelle, Le Cabec Véronique
CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), 205 Route de Narbonne, F-31077 Toulouse, France.
Eur J Cancer. 2009 Feb;45(3):321-7. doi: 10.1016/j.ejca.2008.11.020. Epub 2008 Dec 26.
Hck is a phagocyte specific proto-oncogene of the Src family expressed as two isoforms, p59Hck and p61Hck. It plays a critical role in Bcr/Abl-chronic myeloid leukaemia and is able to transform fibroblasts in vitro. However, the tumourigenic activity of Hck and the respective oncogenic functions of Hck isoforms have not been examined. Tet-Off fibroblasts expressing constitutively active mutants of p59Hck and p61Hck together or individually were used. In contrast to cells expressing p59Hck(ca) or p61Hck(ca) alone, cells expressing both isoforms were transformed in vitro and induced tumour formation in 90% of nude mice within 2 weeks. This is the first demonstration of (i) the tumourigenic activity of Hck in mice, (ii) the cooperative action of the two Hck isoforms in vitro and in vivo. To our knowledge, this is the first example of a transforming activity 'split' in two requisite isoforms.
Hck是Src家族的一种吞噬细胞特异性原癌基因,以两种异构体p59Hck和p61Hck的形式表达。它在Bcr/Abl慢性髓性白血病中起关键作用,并且能够在体外转化成纤维细胞。然而,Hck的致瘤活性以及Hck异构体各自的致癌功能尚未得到研究。使用了共表达或单独表达p59Hck和p61Hck组成型活性突变体的Tet-Off成纤维细胞。与单独表达p59Hck(ca)或p61Hck(ca)的细胞相比,同时表达这两种异构体的细胞在体外发生转化,并在2周内使90%的裸鼠形成肿瘤。这首次证明了:(i) Hck在小鼠中的致瘤活性;(ii) 两种Hck异构体在体外和体内的协同作用。据我们所知,这是转化活性“分裂”为两种必需异构体情况的首个实例。